![Detection Efficacy of 18F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy | Journal of Nuclear Medicine Detection Efficacy of 18F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/jnumed/60/3/362/F1.large.jpg)
Detection Efficacy of 18F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy | Journal of Nuclear Medicine
![Men presenting with prostate‐specific antigen (PSA) values of over 100 ng/mL - Ang - 2016 - BJU International - Wiley Online Library Men presenting with prostate‐specific antigen (PSA) values of over 100 ng/mL - Ang - 2016 - BJU International - Wiley Online Library](https://bjui-journals.onlinelibrary.wiley.com/cms/asset/3efd81b2-6a2a-4897-acde-b2c39477a6ba/bju13411-fig-0007-m.jpg)
Men presenting with prostate‐specific antigen (PSA) values of over 100 ng/mL - Ang - 2016 - BJU International - Wiley Online Library
![Men presenting with prostate‐specific antigen (PSA) values of over 100 ng/mL - Ang - 2016 - BJU International - Wiley Online Library Men presenting with prostate‐specific antigen (PSA) values of over 100 ng/mL - Ang - 2016 - BJU International - Wiley Online Library](https://bjui-journals.onlinelibrary.wiley.com/cms/asset/5a244536-0f0e-461a-bd0b-07c33844c0f0/bju13411-fig-0006-m.jpg)
Men presenting with prostate‐specific antigen (PSA) values of over 100 ng/mL - Ang - 2016 - BJU International - Wiley Online Library
![Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2016/jco.2015.65.34.issue-23/jco.2016.66.7527/20161107/images/medium/jco667527t2.gif)
Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology
![PSA velocity for assessing prostate cancer risk in men with PSA levels between 2.0 and 4.0 ng/ml - ScienceDirect PSA velocity for assessing prostate cancer risk in men with PSA levels between 2.0 and 4.0 ng/ml - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0090429502016461-gr2.gif)
PSA velocity for assessing prostate cancer risk in men with PSA levels between 2.0 and 4.0 ng/ml - ScienceDirect
![Frontiers | Changes of Radiation Treatment Concept Based on 68Ga-PSMA-11-PET/CT in Early PSA-Recurrences After Radical Prostatectomy Frontiers | Changes of Radiation Treatment Concept Based on 68Ga-PSMA-11-PET/CT in Early PSA-Recurrences After Radical Prostatectomy](https://www.frontiersin.org/files/Articles/665304/fonc-11-665304-HTML/image_m/fonc-11-665304-t001.jpg)
Frontiers | Changes of Radiation Treatment Concept Based on 68Ga-PSMA-11-PET/CT in Early PSA-Recurrences After Radical Prostatectomy
![Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2016/jco.2015.65.34.issue-23/jco.2016.66.7527/20161107/images/medium/jco667527t3.gif)
Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer | Journal of Clinical Oncology
Ethnicity Is an Independent Determinant of Age-Specific PSA Level: Findings from a Multiethnic Asian Setting | PLOS ONE
![Table 5.2 from Prostate Specific Antigen (PSA) growth curves: A method to improve prostate cancer screening | Semantic Scholar Table 5.2 from Prostate Specific Antigen (PSA) growth curves: A method to improve prostate cancer screening | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f25d05a5e06f122591c498c5f9971db0b7856847/116-Table5.2-1.png)
Table 5.2 from Prostate Specific Antigen (PSA) growth curves: A method to improve prostate cancer screening | Semantic Scholar
![Serum and tissue monocyte differentiation in PSA value 4–10 ng/mL prostate cancer and benign prostatic hyperplasia | Semantic Scholar Serum and tissue monocyte differentiation in PSA value 4–10 ng/mL prostate cancer and benign prostatic hyperplasia | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b26ee2869d77164beefe3a019ddf3ff39c612841/3-Table1-1.png)
Serum and tissue monocyte differentiation in PSA value 4–10 ng/mL prostate cancer and benign prostatic hyperplasia | Semantic Scholar
![SciELO - Brasil - Does PSA reduction after antibiotic therapy permits postpone prostate biopsy in asymptomatic men with PSA levels between 4 and 10ng/mL? Does PSA reduction after antibiotic therapy permits postpone SciELO - Brasil - Does PSA reduction after antibiotic therapy permits postpone prostate biopsy in asymptomatic men with PSA levels between 4 and 10ng/mL? Does PSA reduction after antibiotic therapy permits postpone](https://minio.scielo.br/documentstore/1677-6119/SWJkYNSwVcVCpfX3JwsTvdm/2b3165cd3e1c5f7e0fee1eea38cf4e7b6a96f59c.jpg)
SciELO - Brasil - Does PSA reduction after antibiotic therapy permits postpone prostate biopsy in asymptomatic men with PSA levels between 4 and 10ng/mL? Does PSA reduction after antibiotic therapy permits postpone
Twenty-year Risk of Prostate Cancer Death by Midlife Prostate-specific Antigen and a Panel of Four Kallikrein Markers in a Large
![PD07-09 EFFECT OF ANASTROZOLE ON PROSTATE SPECIFIC ANTIGEN VALUES IN HYPOGONADAL, SUBFERTILE MEN | Journal of Urology PD07-09 EFFECT OF ANASTROZOLE ON PROSTATE SPECIFIC ANTIGEN VALUES IN HYPOGONADAL, SUBFERTILE MEN | Journal of Urology](https://www.auajournals.org/cms/asset/c9c66b01-d06c-4d3d-8be2-a518d2f39950/fx1.jpg)
PD07-09 EFFECT OF ANASTROZOLE ON PROSTATE SPECIFIC ANTIGEN VALUES IN HYPOGONADAL, SUBFERTILE MEN | Journal of Urology
![Diagnostic Performance and Clinical Impact of 68Ga-PSMA-11 PET/CT Imaging in Early Relapsed Prostate Cancer After Radical Therapy: A Prospective Multicenter Study (IAEA-PSMA Study) | Journal of Nuclear Medicine Diagnostic Performance and Clinical Impact of 68Ga-PSMA-11 PET/CT Imaging in Early Relapsed Prostate Cancer After Radical Therapy: A Prospective Multicenter Study (IAEA-PSMA Study) | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/jnumed/63/2/240/F1.large.jpg)
Diagnostic Performance and Clinical Impact of 68Ga-PSMA-11 PET/CT Imaging in Early Relapsed Prostate Cancer After Radical Therapy: A Prospective Multicenter Study (IAEA-PSMA Study) | Journal of Nuclear Medicine
![Prostate-specific Antigen Density Cutoff of 0.15 ng/ml/cc to Propose Prostate Biopsies to Patients with Negative Magnetic Resonance Imaging: Efficient Threshold or Legacy of the Past? - European Urology Focus Prostate-specific Antigen Density Cutoff of 0.15 ng/ml/cc to Propose Prostate Biopsies to Patients with Negative Magnetic Resonance Imaging: Efficient Threshold or Legacy of the Past? - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/attachment/5300c23d-c590-4dc6-b5df-352d12aeb548/gr1_lrg.jpg)
Prostate-specific Antigen Density Cutoff of 0.15 ng/ml/cc to Propose Prostate Biopsies to Patients with Negative Magnetic Resonance Imaging: Efficient Threshold or Legacy of the Past? - European Urology Focus
![Frontiers | Feasibility and Outcome of PSMA-PET-Based Dose-Escalated Salvage Radiotherapy Versus Conventional Salvage Radiotherapy for Patients With Recurrent Prostate Cancer Frontiers | Feasibility and Outcome of PSMA-PET-Based Dose-Escalated Salvage Radiotherapy Versus Conventional Salvage Radiotherapy for Patients With Recurrent Prostate Cancer](https://www.frontiersin.org/files/Articles/715020/fonc-11-715020-HTML/image_m/fonc-11-715020-t006.jpg)